RAIDODYNAMIC INACTIVATION WITH ACRIDRINE ORANGE ON MOU8SE OSTEOSARCOMA
NOVEL GENOMIC IMBALANCES IN EMBRYONAL RHABDOMYOSARCOMA REVEALED BY COMPARATIVE GENOMIC HYBRIDIZATION AND FLUORESCENCE IN SITU HYBRIDIZATION
IMPACT OF NEOADJUVANT CHEMOTHERAPY ON POSTOPERATIVE MORBIDITY IN SOFT-TISSUE SARCOMAS
THE CLINICAL COURSE OF PATIENTS TREATED FOR BUTTOCK SARCOMA
SURGICAL CULTURE, TECHNIQUES OR ADJUVANT THERAPIES: WHAT IS RELEVANT IN LIMB SAVING FOR SOFT TISSUE SARCOMA
PROSPECTIVE TRIAL OF CONSERVATIVE SURGERY AND SELECTIVE USE OF RADIOTHERAPY FOR T1 EXTREMITY AND TRUNK SOFT TISSUE SARCOMAS (STS)
HIGH GRADE SOFT TlSSUE SARCOMAS OF THE EXTREMITIES TREATED WITHOUT RADITATION. RESULTS FOLLOWING INDUCTION CHEMOTHERAPY AND SURGICAL RESECTION
METASTATlC DISEASE TO THE SOFT TISSUES
PROGNOSTIC FACTORS IN SOFT TISSUE SARCOMAS (STS)
PHASE II STUDY OF IFOSFAMIDE IN MALIGNANT MESOTHELIOMA
LONG-TERM SURVIVAL OF METASTATIC SOFT TISSUE SARCOMAS
COMBINATION CHEMOTHERAPY FOR DESMOID TUMORS
A CASE REPORT OF METASTATIC ANGIOSARCOMA OF THE SPLEEN
EXPRESSION oF P-gp, MRP1 AND LRP IN SOFT TISSUE SARCOMAS